(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Fixed time deposit | 9.60%268.04B | 11.03%255.24B | 12.50%255.98B | 33.23%264.66B | 30.96%244.56B | 35.51%229.89B | 35.01%227.55B | 32.66%198.65B | 43.06%186.75B | 45.32%169.65B |
Reserve deposits | ---- | ---- | ---- | ---- | ---- | ---- | --378.39B | ---- | ---- | ---- |
Cash and equivalents | 39.84%25.99B | 20.93%25.37B | 23.89%21.79B | 31.68%17B | 4.34%18.59B | 19.98%20.98B | 13.76%17.59B | -4.19%12.91B | 5.43%17.81B | -2.84%17.49B |
Reinsurance assets | 1.27%10.1B | 0.73%9.88B | -7.44%9.8B | --10.01B | 151.72%9.97B | --9.81B | 166.01%10.59B | ---- | 8.67%3.96B | ---- |
Refundable deposit | -5.63%1.81B | -6.16%1.8B | 4.02%1.78B | 3.21%1.77B | 11.95%1.92B | 11.78%1.92B | 0.00%1.72B | 0.00%1.72B | 0.00%1.72B | 0.00%1.72B |
Investment income receivable | ---- | ---- | -99.50%76M | ---- | -96.99%413M | ---- | 25.46%15.14B | ---- | 18.89%13.71B | ---- |
Insurance receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3.57%5.86B | 7.04%5.75B | -2.75%4.99B |
Reinsurance receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 220.89%507M | ---- | 455.32%261M |
Financial assets at fair value through profit or loss | 30.79%475.81B | 11.41%423.43B | 378.50%380.24B | 427.28%369.84B | 375.81%363.8B | 435.63%380.08B | 13.16%79.47B | 6.59%70.14B | 118.97%76.46B | 121.15%70.96B |
Available for sale financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1.01%388.31B | ---- | -2.86%396.79B |
Buying back the sale of financial assets | 29.14%8.49B | -83.36%1.06B | -40.49%5.27B | -50.65%5.52B | 145.50%6.57B | -43.04%6.35B | 115.15%8.85B | 141.36%11.18B | -52.69%2.68B | 53.51%11.14B |
Investment in joint ventures and joint ventures | 182.91%16.29B | ---- | -11.10%5.17B | ---- | 4.88%5.76B | ---- | 6.75%5.82B | ---- | 6.52%5.49B | ---- |
Held to maturity investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 19.01%346.85B | 15.66%327.03B | 13.90%309.95B |
Investment property | ---- | -2.56%9.26B | ---- | 2.04%9.39B | ---- | 1.43%9.5B | ---- | 9.21%9.2B | ---- | 9.12%9.36B |
Property plant and equipment | 2.29%18.18B | ---- | 1.51%18.02B | ---- | -1.12%17.77B | ---- | -1.23%17.75B | ---- | 8.31%17.97B | ---- |
Deferred tax assets | ---- | 1,163.36%15.93B | ---- | 83.55%7.6B | ---- | -49.44%1.26B | ---- | 2,045.08%4.14B | ---- | 1,293.30%2.49B |
Protecting a pledge loan | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 8.05%43B | 7.66%42.23B | 7.71%41.54B |
Special items of assets | 7.35%337.59B | 13.43%33.25B | -22.05%351.61B | -71.41%28.28B | -35.28%314.49B | -71.90%29.31B | -6.45%451.1B | 6.78%98.93B | 4.06%485.91B | 20.27%104.32B |
Total assets | 14.17%1.49T | 11.39%1.43T | 15.50%1.4T | 14.15%1.36T | 10.15%1.31T | 12.15%1.28T | 7.73%1.21T | 12.58%1.2T | 16.27%1.19T | 14.57%1.14T |
Liabilities | ||||||||||
Deposit of the Insured | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 17.44%66.96B | ---- | 14.16%61.59B |
Insurance contract | 14.77%1.27T | 15.28%1.22T | 13.16%1.15T | --1.13T | 18.38%1.1T | --1.06T | 17.31%1.01T | ---- | 13.90%932.57B | ---- |
Investment contract | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 18.27%65.27B | ---- |
Reinsurance premium payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 235.90%655M | 379.39%628M | 119.22%730M |
Insurance accounts payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -5.53%5.81B | -12.23%5.8B | -9.16%6.17B |
Dividend for insured | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 128.57%16M | -97.69%15M | 51.65%734M |
Advance payment | ---- | -23.84%262M | ---- | 37.20%343M | ---- | 52.21%344M | ---- | 8.23%250M | 6.67%288M | -23.65%226M |
Reserve for Outstanding Losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 22.00%2.52B | ---- | 20.60%2.14B |
Selling repo securities | ---- | 31.36%75.7B | ---- | 174.73%86.11B | ---- | 104.14%57.63B | ---- | 63.92%31.34B | ---- | 484.11%28.23B |
Financial liabilities measured at fair value through profit or loss | 142.89%9.88B | -59.17%3.24B | -86.12%3.59B | 14.96%10.37B | -47.78%4.07B | -34.78%7.93B | 890.70%25.88B | 334.81%9.02B | 182.82%7.79B | 14.77%12.15B |
Deferred tax liabilities | ---- | -27.03%81M | ---- | 20.69%70M | ---- | 552.94%111M | ---- | -92.76%58M | ---- | -98.48%17M |
Current income tax liabilities | -51.43%17M | -48.16%127M | 23.81%26M | 37.25%210M | -22.22%35M | 99.19%245M | -66.67%21M | -57.73%153M | -78.67%45M | -83.24%123M |
Special items of liabilities | 43.78%127.66B | -2.32%35.53B | 90.17%148.05B | -96.69%32.37B | 23.99%88.79B | -96.09%36.37B | -6.59%77.85B | 12.62%977.46B | 129.76%71.61B | 14.29%929.35B |
Total liabilities | 17.36%1.4T | 14.96%1.34T | 16.23%1.3T | 14.69%1.26T | 10.41%1.2T | 11.45%1.16T | 9.59%1.12T | 14.44%1.1T | 18.38%1.08T | 16.46%1.04T |
Total assets less total liabilities | -19.82%90.05B | -22.69%94.03B | 7.24%105.09B | 8.26%108.34B | 7.45%112.31B | 19.31%121.62B | -9.69%98B | -4.49%100.07B | -1.83%104.52B | -1.77%101.94B |
Equity | ||||||||||
Share capital | 0.00%3.12B | 0.00%3.12B | 0.00%3.12B | 0.00%3.12B | 0.00%3.12B | 0.00%3.12B | 0.00%3.12B | 0.00%3.12B | 0.00%3.12B | 0.00%3.12B |
Reserve | -190.64%-12.85B | ---- | -45.26%9.82B | ---- | -71.52%14.18B | ---- | -66.17%17.95B | ---- | -5.19%49.79B | ---- |
Capital reserves | ---- | -0.06%23.98B | ---- | -0.10%23.98B | ---- | 0.38%23.99B | ---- | 0.41%24B | ---- | -0.04%23.9B |
Hold profit | 5.02%99.76B | ---- | 19.78%92.12B | ---- | 84.13%94.99B | ---- | 46.97%76.91B | ---- | 1.51%51.59B | ---- |
Undistributed profit | ---- | 0.68%97.07B | ---- | 83.28%94.55B | ---- | 79.62%96.41B | ---- | -1.22%51.59B | ---- | 2.73%53.68B |
Special items of shareholders' equity | ---- | 5.55%15.22B | ---- | 62.70%14.42B | ---- | 62.70%14.42B | ---- | 19.52%8.86B | ---- | 19.52%8.86B |
Shareholders' equity | -19.83%90.03B | -22.70%94B | 7.24%105.07B | 8.25%108.31B | 7.45%112.29B | 19.31%121.6B | -9.70%97.98B | -4.49%100.05B | -1.84%104.5B | -1.77%101.92B |
Minority interests | 17.39%27M | 18.18%26M | 19.05%25M | 21.05%23M | 21.05%23M | 22.22%22M | 23.53%21M | 18.75%19M | 26.67%19M | 28.57%18M |
Total equity | -19.82%90.05B | -22.69%94.03B | 7.24%105.09B | 8.26%108.34B | 7.45%112.31B | 19.31%121.62B | -9.69%98B | -4.49%100.07B | -1.83%104.52B | -1.77%101.94B |
Total equity and total liabilities | 14.17%1.49T | 11.39%1.43T | 15.50%1.4T | 14.15%1.36T | 10.15%1.31T | 12.15%1.28T | 7.73%1.21T | 12.58%1.2T | 16.27%1.19T | 14.57%1.14T |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership) | -- | -- | -- | Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data